"The Utility of Procalcitonin as a Biomarker to Predict the Duration of Antibiotic Therapy in Adult Sepsis Patients" by P. Sridharan

Selected Works of Ronald Chamberlain, MD, MPA, FACS

Follow Contact

Article

The Utility of Procalcitonin as a Biomarker to Predict the Duration of Antibiotic Therapy in Adult Sepsis Patients

Journal of Surgical Research (2013)

P. Sridharan, Saint Barnabas Medical Center
R.S. Chamberlain, University of the West Indies
R.S. Chamberlain, University of Medicine and Dentistry of New Jersey
R.S. Chamberlain, Saint Barnabas Medical Center

Link

Disciplines

Medicine and Health Sciences and
Critical Care

Publication Date

February 1, 2013

DOI

10.1016/J.JSS.2012.10.313

Citation Information

P. Sridharan, R.S. Chamberlain, R.S. Chamberlain and R.S. Chamberlain. "The Utility of Procalcitonin as a Biomarker to Predict the Duration of Antibiotic Therapy in Adult Sepsis Patients" Journal of Surgical Research Vol. 179 Iss. 2 (2013) p. 198
Available at: http://works.bepress.com/ronald-chamberlain/103/